Characteristics and Outcomes of COVID-19 Patients Admitted to Intensive Care Units in a Large Health System in

Adeel Nasrullah1, Thejus Jayakrishnan2, Patrick Wedgeworth2

  • 1Pulmonary and Critical Care Medicine, Allegheny Health Network, Pittsburgh, USA.

Cureus
|August 25, 2021
PubMed

Insights

This study found a high mortality rate of 32.8% in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19) in Western Pennsylvania. Key predictors of mortality included age, comorbidities, and severity scores like APACHE.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Limited understanding of factors predicting outcomes for coronavirus disease 2019 (COVID-19) patients in intensive care units (ICUs).
  • Scarcity of data on COVID-19 patient outcomes specifically within Pennsylvania.

Purpose of the Study:

  • To evaluate the characteristics of COVID-19 patients admitted to the ICU.
  • To identify factors associated with adverse outcomes in these patients.
  • To determine predictors of inpatient mortality in COVID-19 ICU admissions.

Main Methods:

  • Retrospective study of 58 COVID-19 patients admitted to ICUs in Western Pennsylvania between March 1, 2020, and April 30, 2020.
  • Analysis included patient demographics, symptoms, comorbidities, vital signs, ICU complications, and interventions.
  • Regression modeling was employed to identify predictors of inpatient mortality, with statistical significance set at P < 0.05.

Main Results:

  • The cohort had a median age of 62 years, with 63.8% males; common symptoms included constitutional and lower respiratory tract issues.
  • High rates of comorbidities (cardiovascular disease 74.1%, obesity 53.5%, diabetes 39.7%) and complications (ARDS 50.0%, shock 41.4%, AKI 41.4%) were observed.
  • Overall inpatient mortality was 32.8%; significant mortality predictors included age, Charlson-comorbidity index, tachypnea, lymphopenia, high APACHE score, shock, ARDS, mechanical ventilation, and steroid use.

Conclusions:

  • This study highlights a substantial inpatient mortality rate among COVID-19 patients requiring ICU care in Western Pennsylvania.
  • Identifying prognostic factors is crucial for risk-stratifying critically ill COVID-19 patients.
  • Further prospective research is warranted to assess the impact of early risk stratification and targeted interventions on patient outcomes.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
529
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
422
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
511
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
407
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
449